Recent Finacing
Recent Raise
GenSight Biologics is a clinical-stage biopharmaceutical company developing gene and optogenetic therapies for mitochondrial and neurodegenerative retinal diseases, employing a mitochondrial targeting sequence platform; lead candidate GS010 targets LHON.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors